Literature DB >> 23709703

Preclinical stroke research: gains and gaps.

David A Greenberg1.   

Abstract

Entities:  

Keywords:  ischemia; neuroprotection; stroke

Mesh：

Year:  2013        PMID： 23709703      PMCID： PMC3723454          DOI： 10.1161/STROKEAHA.113.002088

Source DB:  PubMed          Journal:  Stroke        ISSN： 0039-2499            Impact factor:   7.914


× No keyword cloud information.
  9 in total

Review 1.  Recommendations for standards regarding preclinical neuroprotective and restorative drug development.

Authors: 
Journal:  Stroke       Date:  1999-12       Impact factor: 7.914

2.  Brain Aging and Regeneration after Injuries: an Organismal approach.

Authors:  Ana-Maria Buga; Raluca Vintilescu; Oltin Tiberiu Pop; Aurel Popa-Wagner
Journal:  Aging Dis       Date:  2011-09-20       Impact factor: 6.745

Review 3.  Bench to bedside: the quest for quality in experimental stroke research.

Authors:  Ulrich Dirnagl
Journal:  J Cereb Blood Flow Metab       Date:  2006-03-08       Impact factor: 6.200

Review 4.  Animal models of acute ischaemic stroke: can they predict clinically successful neuroprotective drugs?

Authors:  A J Hunter; A R Green; A J Cross
Journal:  Trends Pharmacol Sci       Date:  1995-04       Impact factor: 14.819

Review 5.  Preclinical stroke research--advantages and disadvantages of the most common rodent models of focal ischaemia.

Authors:  I M Macrae
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

6.  1,026 experimental treatments in acute stroke.

Authors:  Victoria E O'Collins; Malcolm R Macleod; Geoffrey A Donnan; Laura L Horky; Bart H van der Worp; David W Howells
Journal:  Ann Neurol       Date:  2006-03       Impact factor: 10.422

Review 7.  Anaesthetic-related neuroprotection: intravenous or inhalational agents?

Authors:  Daniela Schifilliti; Giovanni Grasso; Alfredo Conti; Vincenzo Fodale
Journal:  CNS Drugs       Date:  2010-11       Impact factor: 5.749

8.  Neuroprotection after focal cerebral ischaemia in hyperglycaemic and diabetic rats.

Authors:  L Bômont; E T MacKenzie
Journal:  Neurosci Lett       Date:  1995-09-01       Impact factor: 3.046

9.  Effect of MK-801 on focal brain infarction in normotensive and hypertensive rats.

Authors:  S Roussel; E Pinard; J Seylaz
Journal:  Hypertension       Date:  1992-01       Impact factor: 10.190
  9 in total
  3 in total

Review 1.  Neuroprotective mechanisms of the ACE2-angiotensin-(1-7)-Mas axis in stroke.

Authors:  Douglas M Bennion; Emily Haltigan; Robert W Regenhardt; U Muscha Steckelings; Colin Sumners
Journal:  Curr Hypertens Rep       Date:  2015-02       Impact factor: 5.369

2.  Activation of the Neuroprotective Angiotensin-Converting Enzyme 2 in Rat Ischemic Stroke.

Authors:  Douglas M Bennion; Emily A Haltigan; Alexander J Irwin; Lauren L Donnangelo; Robert W Regenhardt; David J Pioquinto; Daniel L Purich; Colin Sumners
Journal:  Hypertension       Date:  2015-05-04       Impact factor: 10.190

3.  Are researchers moving away from animal models as a result of poor clinical translation in the field of stroke? An analysis of opinion papers.

Authors:  Pandora Pound; Rebecca Ram
Journal:  BMJ Open Sci       Date:  2020-02-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.